Effect of Fidarestat and Alpha-Lipoic Acid on Diabetes-Induced Vascular Dysfunction
Author Information
Author(s): M. A. Yorek, L. J. Coppey, J. S. Gellett, E. P. Davidson, D. D. Lund
Primary Institution: Veterans Affairs Medical Center and Department of Internal Medicine, University of Iowa
Hypothesis
Can treating diabetic rats with a combination of alpha-lipoic acid and fidarestat enhance the efficacy of alpha-lipoic acid in preventing vascular and neural dysfunction?
Conclusion
The combination therapy of alpha-lipoic acid and fidarestat is more effective in preventing diabetes-induced vascular and neural dysfunction than monotherapy.
Supporting Evidence
- Combination therapy significantly improved motor nerve conduction velocity and endoneurial blood flow.
- Alpha-lipoic acid and fidarestat together were more effective than higher doses of either drug alone.
- Treatment reduced markers of oxidative stress in diabetic rats.
Takeaway
This study shows that giving diabetic rats a mix of two medicines helps their nerves and blood vessels work better than just using one medicine alone.
Methodology
Diabetic rats were treated with different combinations of alpha-lipoic acid and fidarestat, and various physiological parameters were measured.
Potential Biases
Potential bias due to the funding sources and the authors' affiliations.
Limitations
The study was conducted on a specific strain of rats, which may limit the generalizability of the findings.
Participant Demographics
Male Sprague-Dawley rats, 8 to 9 weeks of age.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website